Evidence map›Paper›PMID 34386322›Full record

ReviewActa pharmaceutica Sinica. B2021

Ginsenosides in

Maoqi Hou, Rufeng Wang, Shujuan Zhao, Zhengtao Wang

Open access · diamondAbstract readReview
In one paragraph

Review in Acta pharmaceutica Sinica. B, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 152 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
152citing papers in PubMed, 1 pooled it
14.8field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

152 citing papers in PubMed, 1 synthesis or guideline pooled it, 294 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Review
  5. Review
  6. Review
  7. Review
  8. Host-Microbiota Interactions in Obesity: Immune Metabolic Dysregulation.Obesity reviews : an official journal of the International Association for the Study of Obesity · 2026
    Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. The transcription factorHorticulture research · 2026
    Article
  19. Review
  20. Review

92 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Maoqi HouThe SATCM Key Laboratory for New Resources & Quality Evaluation of Chinese Medicine, The MOE Key Laboratory for Standardization of Chinese Medicines and Shanghai Key Laboratory of Compound Chinese Medicines, Institute of Chinese Materia Medica, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China.
Rufeng WangThe SATCM Key Laboratory for New Resources & Quality Evaluation of Chinese Medicine, The MOE Key Laboratory for Standardization of Chinese Medicines and Shanghai Key Laboratory of Compound Chinese Medicines, Institute of Chinese Materia Medica, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China.
Shujuan ZhaoThe SATCM Key Laboratory for New Resources & Quality Evaluation of Chinese Medicine, The MOE Key Laboratory for Standardization of Chinese Medicines and Shanghai Key Laboratory of Compound Chinese Medicines, Institute of Chinese Materia Medica, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China.
Zhengtao WangThe SATCM Key Laboratory for New Resources & Quality Evaluation of Chinese Medicine, The MOE Key Laboratory for Standardization of Chinese Medicines and Shanghai Key Laboratory of Compound Chinese Medicines, Institute of Chinese Materia Medica, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China.
State Administration of Traditional Chinese Medicine of the People's Republic of China · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Ginsenosides are a series of glycosylated triterpenoids which belong to protopanaxadiol (PPD)-, protopanaxatriol (PPT)-, ocotillol (OCT)- and oleanane (OA)-type saponins known as active compounds of

Indexed as

ABA, abscisic acidADP, adenosine diphosphateAtCPR (ATR), Arabidopsis thaliana cytochrome P450 reductaseBARS, baruol synthaseBiosynthetic pathwayBiotechnological approachCAS, cycloartenol synthaseCDP, cytidine diphosphateCPQ, cucurbitadienol synthaseCYP, cytochrome P450DDS, dammarenediol synthaseDMAPP, dimethylallyl diphosphateDM, dammarenediol-IIFPP, farnesyl pyrophosphateFPPS (FPS), farnesyl diphosphate synthaseGDP, guanosine diphosphateGinsenosideHEJA, 2-hydroxyethyl jasmonateHMGR, HMG-CoA reductaseIPP, isopentenyl diphosphateITS, internal transcribed spacerJA-Ile, (+)-7-iso-jasmonoyl-l-isoleucineJA, jasmonic acidJAR, JA-amino acid synthetaseJAZ, jasmonate ZIM-domainKcMS, Kandelia candel multifunctional triterpene synthasesLAS, lanosterol synthaseLUP, lupeol synthaseMeJA, methyl jasmonateMEP, methylerythritol phosphateMVA, mevalonateMVD, mevalonate diphosphate decarboxylaseNDP, nucleotide diphosphateNon-coding RNAsOA, oleanane or oleanic acidOAS, oleanolic acid synthaseOCT, ocotillolOSC, oxidosqualene cyclasePanax speciesPPD, protopanaxadiolPPDS, PPD synthasePPT, protopanaxatriolPPTS, PPT synthaseRNAi, RNA interferenceSA, salicylic acidSE (SQE), squalene epoxidaseSPL, squamosa promoter-binding protein-likeSS (SQS), squalene synthaseSUS, sucrose synthaseTDP, thymine diphosphateTranscription factorsUDP, uridine diphosphateUGPase, UDP-glucose pyrophosphosphprylaseUGT, UDP-dependent glycosyltransferaseWGD, whole genome duplicationα-AS, α-amyrin synthaseβ-AS, β-amyrin synthase

Identifiers

PMID34386322
PMCPMC8343117
OpenAlexW3120104635

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.